Dose-dependent and tissue-specific adverse effects of exogenous glucocorticoids: insights for optimizing clinical practice.
Pofi R. et al, (2025), J Endocrinol Invest
Venous thromboembolism in patients with pituitary adenoma: UK multicentre cohort study.
Isand K. et al, (2025), Eur J Endocrinol
Is It Possible to Screen for Primary Aldosteronism Effectively in Primary Care?
Dissanayake HA. et al, (2025), Clin Endocrinol (Oxf)
Chronotherapy with Once-Daily Osilodrostat Improves Cortisol Rhythm, Quality of Life, and Sleep in Cushing's Syndrome.
Ferrari D. et al, (2025), J Clin Endocrinol Metab
Exploring the interplay of karyotype, hormones, sexuality, and body image perception in individuals with Turner syndrome.
Tarantino C. et al, (2025), J Endocrinol Invest
New Approaches to the Treatment of Hypercortisolism.
Pofi R. et al, (2025), Annu Rev Med, 76, 431 - 445
Circadian clock disruption impairs immune oscillation in chronic endogenous hypercortisolism: a multi-level analysis from a multicentre clinical trial.
Hasenmajer V. et al, (2024), EBioMedicine, 110
Impact of Female Sex and Mild Cortisol Secretion on Coagulation Profile in Adrenal Incidentalomas.
Bonaventura I. et al, (2024), Journal of the Endocrine Society, 9
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study.
De Alcubierre D. et al, (2024), Pituitary
Cardiac magnetic resonance reveals biventricular impairment in Cushing's syndrome: a multicentre case-control study.
Feola T. et al, (2024), Endocrine
Development of diagnostic algorithm for Cushing's syndrome: a tertiary centre experience.
Efthymiadis A. et al, (2024), J Endocrinol Invest
Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study.
Bonaventura I. et al, (2024), J Endocrinol Invest
Copeptin and the syndrome of inappropriate antidiuresis (SIAD) after pituitary transsphenoidal surgery
Efthymiadis A. et al, (2024), Endocrinology, Diabetes and Metabolism, 7
MASLD IS A NIGHT-TIME DISEASE DRIVEN BY NOCTURNAL HEPATIC, ADIPOSE, AND SKELETAL MUSCLE INSULIN RESISTANCE
Marjot T. et al, (2024), HEPATOLOGY, 80, S443 - S443
Effects of Dual-Release Hydrocortisone on Bone Metabolism in Primary and Secondary Adrenal Insufficiency: A 6-Year Study.
Hasenmajer V. et al, (2023), J Endocr Soc, 8
Pituitary adenoma consistency affects postoperative hormone function: a retrospective study
De Alcubierre D. et al, (2023), BMC Endocrine Disorders, 23
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
Pofi R. et al, (2023), Endocr Rev, 44, 975 - 1011